How a joined-up development strategy pays off for early-stage biotechs

Back to Insights Home

Parexel Biotech’s Nate Akers - VP of Business Development, and Vicky Hsu - Head of Operations in Asia, discuss how important it is for biotechs to align clinical execution with a clearly defined regulatory strategy to increase the chance of success for a new drug program.


Back to Insights Home